The GAVI Alliance Board, meeting in Phnom Penh, Cambodia, took a number of decisions on additional vaccines for the Alliance’s future portfolio, having received detailed analysis on five disease areas as part of the Vaccine Investment Strategy. The Board:
:: Decided new support would be made available for additional yellow fever campaigns in light of a resurgence of the disease in some parts of Africa.
:: Approved a contribution towards a global cholera vaccine stockpile for the period 2014-2018 to increase access to oral cholera vaccine in outbreak situations and endemic settings.
:: Agreed to continue to consider support for a malaria vaccine if and when one is licensed, prequalified by the WHO and recommended for use by the joint meeting of the WHO Strategic Advisory Group of Experts (SAGE) and the Malaria Programme Advisory Committee (expected in 2015), taking into account updated projections of impact, cost and country demand.
:: Concluded that further evidence is necessary on the impact and operational feasibility of supporting the important rabies vaccine as well as influenza vaccines for pregnant women. The Board agreed that GAVI will fund an observational study to address critical knowledge gaps around access to rabies vaccine and will monitor the evolving evidence base for maternal influenza vaccination in coming years.
Full media Release:  Phnom Penh, 22 November 2013 –   http://www.gavialliance.org/library/news/press-releases/2013/gavi-alliance-to-support-introduction-of-inactivated-polio-vaccine-in-worlds-73-poorest-countries/